Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 382

1.

Impact of high-dose interferon induction and ribavirin therapy in patients with chronic hepatitis C relapsing after or not responding to interferon monotherapy.

Steindl-Munda P, Ferenci P, Brunner H, Nachbaur K, Datz C, Gschwantler M, Hofer H, Stauber R, Hackl F, Jessner W, Rosenbeiger M, Gangl A, Vogel W; Austrian Hepatitis Study Group.

Liver Int. 2003 Aug;23(4):269-75.

PMID:
12895267
[PubMed - indexed for MEDLINE]
2.

High-dose interferon alpha-2b induction therapy in combination with ribavirin for Japanese patients infected with hepatitis C virus genotype 1b with a high baseline viral load.

Tsubota A, Arase Y, Suzuki F, Suzuki Y, Akuta N, Hosaka T, Someya T, Kobayashi M, Saitoh S, Ikeda K, Kumada H.

J Gastroenterol. 2004;39(2):155-61.

PMID:
15069622
[PubMed - indexed for MEDLINE]
3.

A randomized trial of high-dose interferon alpha-2b, with or without ribavirin, in chronic hepatitis C patients who have not responded to standard dose interferon.

Malik AH, Kumar KS, Malet PF, Ostapowicz G, Adams G, Wood M, Yarbrough K, Jones A, Lee WM.

Aliment Pharmacol Ther. 2002 Mar;16(3):381-8.

PMID:
11876690
[PubMed - indexed for MEDLINE]
Free Article
4.

Efficacy of interferon alpha-2b induction therapy before retreatment for chronic hepatitis C.

Carr C, Hollinger FB, Yoffe B, Wakil A, Phillips J, Bzowej N, Leung J, Mirro K, Poordad F, Moore DH, Gish RG.

Liver Int. 2007 Oct;27(8):1111-8.

PMID:
17845540
[PubMed - indexed for MEDLINE]
5.

Combined treatment of relapse of chronic hepatitis C with high-dose alpha2b interferon plus ribavirin for 6 or 12 months.

Di Marco V, Almasio P, Vaccaro A, Ferraro D, Parisi P, Cataldo MG, Di Stefano R, Craxì A.

J Hepatol. 2000 Sep;33(3):456-62.

PMID:
11020002
[PubMed - indexed for MEDLINE]
6.

Early viral kinetics and treatment outcome in combination of high-dose interferon induction vs. pegylated interferon plus ribavirin for naive patients infected with hepatitis C virus of genotype 1b and high viral load.

Tsubota A, Arase Y, Someya T, Suzuki Y, Suzuki F, Saitoh S, Ikeda K, Akuta N, Hosaka T, Kobayashi M, Kumada H.

J Med Virol. 2005 Jan;75(1):27-34.

PMID:
15543591
[PubMed - indexed for MEDLINE]
7.

A randomized 4-arm multicenter study of interferon alfa-2b plus ribavirin in the treatment of patients with chronic hepatitis C relapsing after interferon monotherapy.

Saracco G, Olivero A, Ciancio A, Carenzi S, Smedile A, Cariti G, Andreoni M, Orsi PG, Biglino A, Tabone M, Roffi L, Croce G, Manca A, Tappero G, Ciccone G, Rizzetto M.

Hepatology. 2002 Oct;36(4 Pt 1):959-66.

PMID:
12297844
[PubMed - indexed for MEDLINE]
8.

Induction pegylated interferon alfa-2b in combination with ribavirin in patients with genotypes 1 and 4 chronic hepatitis C: a prospective, randomized, multicenter, open-label study.

Brady DE, Torres DM, An JW, Ward JA, Lawitz E, Harrison SA.

Clin Gastroenterol Hepatol. 2010 Jan;8(1):66-71.e1. doi: 10.1016/j.cgh.2009.08.036. Epub 2009 Sep 10.

PMID:
19747986
[PubMed - indexed for MEDLINE]
9.

Early viral clearance and sustained response in chronic hepatitis C: a controlled trial of interferon and ribavirin after high-dose interferon induction.

Di Marco V, Ferraro D, Almasio P, Vaccaro A, Parisi P, Cappello M, Cino N, Di Stefano R, Craxì A.

J Viral Hepat. 2002 Sep;9(5):354-9.

PMID:
12225330
[PubMed - indexed for MEDLINE]
10.

Efficacy of high-dose interferon in combination with ribavirin in patients with chronic hepatitis C resistant to interferon alone.

Min AD, Jones JL, Esposito S, Lebovics E, Jacobson IM, Klion FM, Goldman IS, Geders JM, Tobias H, Bodian C, Bodenheimer HC Jr.

Am J Gastroenterol. 2001 Apr;96(4):1143-9.

PMID:
11316161
[PubMed - indexed for MEDLINE]
11.

Efficacy of a short-term ribavirin plus interferon alpha combination therapy followed by interferon alpha alone in previously untreated patients with chronic hepatitis C: a randomized multicenter trial.

Berg T, Hoffmann RM, Teuber G, Leifeld L, Lafrenz M, Baumgarten R, Spengler U, Zeuzem S, Pape GR, Hopf U.

Liver. 2000 Dec;20(6):427-36.

PMID:
11169056
[PubMed - indexed for MEDLINE]
12.

Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.

Shepherd J, Brodin H, Cave C, Waugh N, Price A, Gabbay J.

Health Technol Assess. 2004 Oct;8(39):iii-iv, 1-125. Review.

PMID:
15461877
[PubMed - indexed for MEDLINE]
Free Article
13.

A randomized trial of pegylated interferon alpha-2b plus ribavirin in the retreatment of chronic hepatitis C.

Jacobson IM, Gonzalez SA, Ahmed F, Lebovics E, Min AD, Bodenheimer HC Jr, Esposito SP, Brown RS Jr, Bräu N, Klion FM, Tobias H, Bini EJ, Brodsky N, Cerulli MA, Aytaman A, Gardner PW, Geders JM, Spivack JE, Rahmin MG, Berman DH, Ehrlich J, Russo MW, Chait M, Rovner D, Edlin BR.

Am J Gastroenterol. 2005 Nov;100(11):2453-62.

PMID:
16279900
[PubMed - indexed for MEDLINE]
14.

Daily interferon induction regimen using different manufactured interferons (alpha-2A or alpha-2B) in combination with ribavirin for treatment of chronic hepatitis C: a prospective randomized study.

Braga EL, Lyra AC, Nascimento L, Netto E, Kalabrik L, Lyra LG.

Arq Gastroenterol. 2006 Oct-Dec;43(4):275-9.

PMID:
17406754
[PubMed - indexed for MEDLINE]
Free Article
15.

Reinforced interferon alpha-2b and ribavirin is more effective than standard combination therapy in the retreatment of chronic hepatitis C previously nonresponsive to interferon: a randomized trial.

Poynard T, Marcellin P, Bissery A, Myers RP, Moussalli J, Degos F, Dhumeaux D, Riachi G, Bronowicki JP, Brissot P, Buffet C, Serfaty L, Naveau S, Sogni P, Beaugrand M, Gayno S, Larrey D, Samuel D, Eugene C, Pol S, Bedossa P, Daurat V, Chaumet-Riffaud P; GER-CYT-RIBANON group.

J Viral Hepat. 2003 May;10(3):197-204.

PMID:
12753338
[PubMed - indexed for MEDLINE]
16.

Combination of interferon induction therapy and ribavirin in chronic hepatitis C.

Ferenci P, Brunner H, Nachbaur K, Datz C, Gschwantler M, Hofer H, Stauber R, Hackl F, Jessner W, Rosenbeiger M, Munda-Steindl P, Hegenbarth K, Gangl A, Vogel W; Australian Hepatitis Study Group.

Hepatology. 2001 Nov;34(5):1006-11.

PMID:
11679972
[PubMed - indexed for MEDLINE]
17.

The pattern of response to interferon alpha (alpha-IFN) predicts sustained response to a 6-month alpha-IFN and ribavirin retreatment for chronic hepatitis C. TVVH Study Group.

Cavalletto L, Chemello L, Donada C, Casarin P, Belussi F, Bernardinello E, Marino F, Pontisso P, Gatta A, Alberti A.

J Hepatol. 2000 Jul;33(1):128-34.

PMID:
10905596
[PubMed - indexed for MEDLINE]
18.

A randomized trial to assess the efficacy of interferon alpha in combination with ribavirin in the treatment of interferon alpha nonresponders with chronic hepatitis C: superior efficacy of high daily dosage of interferon alpha in genotype 1.

Tassopoulos NC, Tsantoulas D, Raptopoulou M, Vassiliadis T, Kanatakis S, Paraskevas E, Vafiadis I, Avgerinos A, Tzathas C, Manolakopoulos S, Ketikoglou I, Aggelis P, Goritsas K, Giannoulis G, Hatzis G G, Thomopoulos K, Akriviadis E, Sypsa V, Hatzakis A.

J Viral Hepat. 2003 May;10(3):189-96.

PMID:
12753337
[PubMed - indexed for MEDLINE]
19.

Retreatment for 24 vs 48 weeks with interferon-alpha2b plus ribavirin of chronic hepatitis C patients who relapsed or did not respond to interferon alone.

Enríquez J, Gallego A, Torras X, Pérez-Olmeda T, Diago M, Soriano V, Luján MS, García-Samaniego J.

J Viral Hepat. 2000 Nov;7(6):403-8.

PMID:
11115050
[PubMed - indexed for MEDLINE]
20.

A randomized trial of prolonged high dose of interferon plus ribavirin for hepatitis C patients nonresponders to interferon alone.

Fattovich G, Zagni I, Ribero ML, Castagnetti E, Minola E, Lomonaco L, Scattolini C, Fabris P, Boccia S, Giusti M, Abbati G, Felder M, Rovere P, Redaelli A, Tonon A, Tomba A, Montanari R, Paternoster C, Distasi M, Fornaciari G, Tositti G, Rizzo C, Suppressa S, Pantalena M, Noventa F, Tagger A.

J Viral Hepat. 2004 Nov;11(6):543-51.

PMID:
15500555
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk